Brunner DP, Dijk DJ, Münch M, Borbély AA. Effect of zolpidem on sleep and sleep EEG spectra in healthy young men. Psychopharmacology (Berl) 1991;104(1):1–5.
Diagnostic and Statistical Manual of Mental Disorders: Diagnostic Criteria for Primary Insomnia. FourthEdition. American Psychiatric Association 2000:597–661.
Leger D, Laudon M and Zisapel N. Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy. The American Journal of Medicine 2004;116(2):91–95.
Lemoine P, Nir T, Laudon M, Zisapel N. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. J Sleep Res 2007;16:372–380.
NEURIM 1, study report.
Otmani S, et al. 2008 (submitted).
Paul MA, Gray G, Sardana TM, Pigeau RA. Melatonin and zopiclone as facilitators of early circadian sleep in operational air transport crews. Aviat Space Environ Med 2004;75(5):439–443.
Traschsel L, Dijk DJ, Brunner DP, et al. Effect of zopiclone and midazolam on sleep and EEG spectra in a phase-advacned sleep schedule. Neuropsychopharmacology 1990;3(1):11–18.
Tyrer P, Murphy S, Riley P. The Benzodiazepine Withdrawal Symptom Questionnaire. Journal of Affective Disorders 1990;19:53-61.
Wade AG, Ford I, Crawford G, et al. Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness. Curr Med Res Opin 2007;23(10):2597–2605.
Waldhauser F, Waldhauser M, Lieberman HR, et al. Bioavailability of oral melatonin in humans. Neuroendocrinology 1984:307–313.
